II.2 Tamoxifen and benign endometrial lesions

X. De Muylder; Patrick Neven; Yves Van Belle

doi:10.1016/s0959-8049(98)00091-4

II.2 Tamoxifen and benign endometrial lesions

X. De Muylder, Patrick Neven, Yves Van Belle

In: European Journal of Cancer · 1998 · vol. 34 , pp. S18–S19 · doi:10.1016/s0959-8049(98)00091-4 · W2083788074

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This paper investigated the relationship between tamoxifen use and benign endometrial lesions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (10)

Pathology of endometrium treated with tamoxifen. via openalex
TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM via openalex
W2019550358 via openalex
W2030526344 via openalex
W2057044871 via openalex
W2075870373 via openalex
W2438890976 via openalex
W1965740586 via openalex
W6718289250 via openalex
W1973254088 via openalex

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall: last seen: 2026-09-19T06:31:22.526400+00:00

License: CC0 · commercial use OK

[1] TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM 1989

[2] Pathology of endometrium treated with tamoxifen. 1994